Author

Florian Rieder 1

1 CLEVELAND CLINIC FOUNDATION

3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn’s Disease 2016: Part 1: Diagnosis and Medical Management

Fernando Gomollon Garcia, Axel Dignass, Vito Annese, Herbert Tilg, Gert Van Assche, James Lindsay, Laurent Peyrin-Biroulet, Garret Cullen, Marco Daperno, Torsten Kucharzik, Florian Rieder, Sven Almer, Alessandro Armuzzi, Marcus Harbord, Jost Langhorst, Miquel Sans, Yehuda Chowers, Gionata Fiorino, Pascal Juillerat, Geras

A HIGHER INDUCTION DOSING REGIMEN OF ADALIMUMAB DOES NOT ENHANCE MODULATION OF DOWNSTREAM BLOOD MOLECULAR MARKERS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE OR ULCERATIVE COLITIS: RESULTS FROM THE SERENE-CD AND SERENE-UC STUDIES

Marc Ferrante, Valerie Pivorunas, James Butler, Naim Mahi, Nael M. Mostafa, Melanie Ruzek, James Fann, Feng Hong, Xiaohong Cao, Nizar Smaoui, Justin Wade Davis, Jasmina Kalabic, Alexandra Song, Heath M. Guay, Florian Rieder, Julian Panés, Jean-Frédéric Colombel

ACTIVATION OF TOLL-LIKE RECEPTOR (TLR) 5 BY FLAGELLIN INDUCES A PRO-FIBROGENIC PHENOTYPE IN HUMAN INTESTINAL FIBROBLASTS (HIF) – A NOVEL PATHWAY MEDIATED BY MYD88 AND CASPASE 1

Florian Rieder, Shardul Bhilocha, Anja Schirbel, Zhufeng Ouyang, Gail West, Hyunjin Rho, Carol de la Motte, Claudio Fiocchi

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 1: Initial diagnosis, monitoring of known IBD, detection of complications

Christian Maaser, Andreas Sturm, Stephan Vavricka, Torsten Kucharzik, Gionata Fiorino, Vito Annese, Emma Calabrese, Daniel C. Baumgart, Dominik Bettenworth, Paula Borralho-Nunes, Johan Burisch, Fabiana Castiglione, Abraham (Rami) Eliakim, Pierre Ellul, Iago González Lama, Hannah Gordon, Steve Halligan, Konstantinos H. Kats

ECCO-ESGAR Guideline for Diagnostic Assessment in IBD Part 2: IBD scores and general principles and technical aspects

Andreas Sturm, Christian Maaser, Emma Calabrese, Vito Annese, Gionata Fiorino, Torsten Kucharzik, Stephan Vavricka, Bram Verstockt, Patrick Van Rheenen, Damian Tolan, Stuart Taylor, Jordi Rimola, Florian Rieder, Jimmy K. Limdi, Andrea Laghi, Eduards Krustins, Paulo Gustavo Kotze, Uri Kopylov, Konstantinos H. Katsanos, St

EFFICACY OF DEUCRAVACITINIB, AN ORAL, SELECTIVE, TYROSINE KINASE 2 INHIBITOR, IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS AND PRIOR EXPOSURE TO BIOLOGIC THERAPY: SUBANALYSIS FROM THE PHASE 2 LATTICE-UC STUDY

Stefan Schreiber, Nicholas Powell, Florian Rieder, Anita Afzali, Yi Luo, Mark T. Osterman, Chun Wu, Lisu Wang, Courtney Radosti, Aditya Patel

EFFICACY OF MIRIKIZUMAB IN RESOLVING ACTIVE HISTOLOGIC INFLAMMATION IN ULCERATIVE COLITIS IN LUCENT-1 INDUCTION AND LUCENT-2 MAINTENANCE TRIALS

Fernando Magro, Rish Pai, Taku Kobayashi, Vipul Jairath, Florian Rieder, Isabel Redondo, Trevor Lissoos, Nathan Morris, Mingyang Shan, Laurent Peyrin-Biroulet

EFFICACY, SAFETY AND LONG TERM OUTCOME OF ENDOSCOPIC DILATION THERAPY FOR STRICTURING CROHN’S DISEASE - A COMBINED ANALYSIS OF 3252 ENDOSCOPIC BALLOON DILATIONS PROCEDURES

Dominik Bettenworth, Rocio Lopez, Anders Gustavsson, Curt Tysk, Florian Rieder

EFFICACY, SAFETY AND LONG-TERM OUTCOME OF ENDOSCOPIC DILATION THERAPY FOR PRIMARY CROHN’S DISEASE STRICTURES OF THE UPPER GASTROINTESTINAL TRACT – AN INTERNATIONAL MULTICENTER COMBINED ANALYSIS

Dominik Bettenworth, Marcus M. Mücke, Amandeep Singh, Rocio Lopez, Martin Goetz, Toshiyuki Matsui, John Gásdal Karstensen, Nik Sheng Ding, Tian Bai Qui, Jochen Hampe, Katja Matthes, Piero V Valli, Gerhard Rogler, Florian Rieder

EFFICACY, SAFETY AND LONG-TERM OUTCOME OF ENDOSCOPIC DILATION THERAPY FOR STRICTURING CROHN?S DISEASE OF THE UPPER GASTROINTESTINAL TRACT - A COMBINED ANALYSIS OF 127 ENDOSCOPIC BALLOON DILATION PROCEDURES

Dominik Bettenworth, Marcus M. Mücke, Amandeep Singh, Rocio Lopez, Florian Rieder

Item 1 - 10 / 30
1
2 3